U.C. Bakar Fellows Program
513 Parnassus Ave Med. Sci. Building S-1332, San Francisco, CA, 94143, United States
Overview
The Bakar Fellows Program supports UC Berkeley faculty in cultivating commercial applications in STEM+ fields.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Association
- Commercial
- Education
Investment portfolio
- Zephyrus Biosciences
Participated · Equity · Sep 2014
Zephyrus Biosciences commercializes an scWestern system that performs Western-blot–style protein analysis on thousands of individual cells using microfluidics. The technology emerged from over five years of research in Professor Amy Herr’s lab at UC Berkeley and was published in Nature Methods in June 2014. The company holds an exclusive license from UC Berkeley and is led by founders Drs. Kelly Gardner, Josh Molho, and Amy Herr. Zephyrus’s team includes biologists and engineers with prior industry experience at companies such as Applied Biosystems, Caliper Life Sciences, Affymetrix, Agilent, Millipore and Illumina. The announced financing will support development and commercialization of the scWestern system. Zephyrus is affiliated with QB3, BayBio, StartX Med, and Berkeley SkyDeck.
Team
No current team members are available.